Dr BOUDALI Lotfi

Fiche personne

Directeur de la recherche et de l'innovation

Coordonnées

Institut Strauss
3 rue de la Porte de l'Hôpital
BP 30042
67065 STRASBOURG Cedex

Territoire

Alsace

Statut

Hospitalier

Affiliation

Institut Strauss (IS)

Équipes/plateformes

Laboratoire de recherche nanotranslationnelle

Publications

Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar.

Bischoff H, O'Connor NK, Kim J, Popescu BV, Bigot C, Pradhan S, Chakraborty R, Jaison L, Majeed F, Park LS, Boudali L, Detappe A, Pivot X, Coliat P

Drugs R D. 2025 04 2;:

Landscape of Subcutaneous Administration Strategies for Monoclonal Antibodies in Oncology.

Jacquot G, Lopez Navarro P, Grange C, Boudali L, Harlepp S, Pivot X, Detappe A

Adv Mater. 2024 08 20;:e2406604

Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.

Pham FY, Jacquet E, Taleb A, Monard A, Kerouani-Lafaye G, Turcry F, Brunel L, Grudé F, Yoldjian I, Sainte-Marie I, Boudali L, Blay JY, Albin N

Int J Cancer. 2022 10 15;151(8):1345-1354

Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal F-fluorocholine PET/CT: 1084 examinations.

Chevalme YM, Boudali L, Gauthé M, Rousseau C, Skanjeti A, Merlin C, Robin P, Giraudet AL, Janier M, Talbot JN

Eur J Nucl Med Mol Imaging. 2021 08;48(9):2935-2950

Access to innovation through the national early access program and clinical trials for patients with malignant melanoma.

Christen C, Belgodère L, Guillot B, Jumeau C, Lorence A, Kerouani-Lafaye G, Brunel L, Turcry F, Monard A, Grudé F, Guyader G, Boudali L, Albin N

Cancer. 2021 07 1;127(13):2262-2270

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years.

Jacquet E, Kerouani-Lafaye G, Grude F, Goncalves S, Lorence A, Turcry F, Brunel L, Belgodere L, Monard A, Guyader G, Boudali L, Albin N

Eur J Cancer. 2021 05;149:82-90

Evaluation of Clinical Trials in Onco-haematology: A New Method Based on Risk Analysis and Multidisciplinarity.

Lapière J, Christen C, Kerouani-Lafaye G, Monard A, Turcry F, Grude F, Gazin V, Burbank M, Chocarne P, Taleb A, Belgodere L, Brunel L, Chu C, Deligny C, Ake E, Gonçalves S, Bouheret P, Barbou-des-Courières S, Sainte-Marie I, Guyader G, Boudali L, Albin N

Ther Innov Regul Sci. 2021 05;55(3):601-611

Short-Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care.

Bouillon K, Bertrand M, Boudali L, Ducimetière P, Dray-Spira R, Zureik M

J Am Heart Assoc. 2016 10 31;5(11):

Voir plus

Fiche personne Publications

Retrouvez aussi

Unités de recherche, établissements

Projets de recherche

Publications scientifiques